Trgovina FibroGen, Inc - FGEN CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.30 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
FibroGen Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Ključni statistični podatki
| Predhodno. Zapri* | 19.05 |
| Odpri* | 18.87 |
| Enoletna sprememba* | 89.65% |
| Dnevni razpon* | 18.54 - 19.03 |
| Razpon 52 wk | 8.67-25.69 |
| Povprečni obseg (10 dni) | 1.03M |
| Povprečni obseg (3 meseci) | 18.80M |
| Tržna kapitalizacija | 1.87B |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 97.58M |
| Prihodki | 116.07M |
| EPS | -3.27 |
| Dividenda (donosnost v %) | N/A |
| Beta | 0.79 |
| Datum naslednjega zaslužka | Aug 7, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Jun 6, 2023 | 18.54 | -0.46 | -2.42% | 19.00 | 19.14 | 18.53 |
| Jun 5, 2023 | 19.05 | 1.83 | 10.63% | 17.22 | 19.43 | 17.22 |
| Jun 2, 2023 | 17.79 | -0.94 | -5.02% | 18.73 | 19.05 | 17.34 |
| Jun 1, 2023 | 17.18 | 0.22 | 1.30% | 16.96 | 17.59 | 16.70 |
| May 31, 2023 | 17.16 | 0.15 | 0.88% | 17.01 | 17.61 | 16.72 |
| May 30, 2023 | 17.04 | 0.47 | 2.84% | 16.57 | 17.33 | 16.46 |
| May 26, 2023 | 16.65 | 0.03 | 0.18% | 16.62 | 16.80 | 16.33 |
| May 25, 2023 | 16.82 | 0.16 | 0.96% | 16.66 | 16.91 | 16.44 |
| May 24, 2023 | 16.90 | -0.05 | -0.29% | 16.95 | 17.33 | 16.51 |
| May 23, 2023 | 17.27 | 0.06 | 0.35% | 17.21 | 18.03 | 16.99 |
| May 22, 2023 | 17.16 | -0.14 | -0.81% | 17.30 | 18.02 | 16.96 |
| May 19, 2023 | 17.49 | -0.07 | -0.40% | 17.56 | 18.07 | 17.20 |
| May 18, 2023 | 17.53 | 0.01 | 0.06% | 17.52 | 17.89 | 17.29 |
| May 17, 2023 | 17.77 | 0.80 | 4.71% | 16.97 | 17.86 | 16.92 |
| May 16, 2023 | 17.40 | 0.25 | 1.46% | 17.15 | 17.51 | 17.08 |
| May 15, 2023 | 17.58 | 0.46 | 2.69% | 17.12 | 17.91 | 17.03 |
| May 12, 2023 | 17.31 | -0.11 | -0.63% | 17.42 | 17.66 | 17.09 |
| May 11, 2023 | 17.48 | -0.12 | -0.68% | 17.60 | 18.00 | 17.38 |
| May 10, 2023 | 17.65 | 0.25 | 1.44% | 17.40 | 17.84 | 17.17 |
| May 9, 2023 | 17.30 | 1.25 | 7.79% | 16.05 | 17.89 | 15.97 |
FibroGen, Inc Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| Wednesday, June 7, 2023 | ||
| Čas (UTC) (UTC) 15:00 | Država US
| Dogodek FibroGen Inc Annual Shareholders Meeting FibroGen Inc Annual Shareholders MeetingForecast -Previous - |
| Thursday, June 8, 2023 | ||
| Čas (UTC) (UTC) 18:30 | Država US
| Dogodek FibroGen Inc at Jefferies Healthcare Conference FibroGen Inc at Jefferies Healthcare ConferenceForecast -Previous - |
| Monday, June 12, 2023 | ||
| Čas (UTC) (UTC) 18:20 | Država US
| Dogodek FibroGen Inc at Goldman Sachs Healthcare Conference FibroGen Inc at Goldman Sachs Healthcare ConferenceForecast -Previous - |
| Friday, June 16, 2023 | ||
| Čas (UTC) (UTC) 15:00 | Država US
| Dogodek FibroGen Inc Annual Shareholders Meeting FibroGen Inc Annual Shareholders MeetingForecast -Previous - |
| Monday, August 7, 2023 | ||
| Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q2 2023 FibroGen Inc Earnings Release Q2 2023 FibroGen Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q3 2023 FibroGen Inc Earnings Release Q3 2023 FibroGen Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Skupni prihodki | 140.734 | 235.309 | 176.319 | 256.577 | 212.958 |
| Prihodki | 140.734 | 235.309 | 176.319 | 256.577 | 212.958 |
| Celotni odhodki iz poslovanja | 441.759 | 523.839 | 368.199 | 345.891 | 299.651 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 127.474 | 120.557 | 97.238 | 126.557 | 63.812 |
| Raziskave in razvoj | 296.791 | 387.043 | 252.924 | 209.265 | 235.839 |
| Prihodki iz poslovanja | -301.025 | -288.53 | -191.88 | -89.314 | -86.693 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 6.156 | -2.153 | 3.151 | 12.672 | 0.577 |
| Čisti dobiček pred obdavčitvijo | -294.869 | -290.683 | -188.729 | -76.642 | -86.116 |
| Čisti dobiček po davkih | -295.227 | -291.03 | -189.089 | -76.97 | -86.42 |
| Čisti dobiček pred dodatnimi postavkami | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
| Čisti dobiček | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
| Popravljen čisti dobiček | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
| Popravljene ponderirane povprečne delnice | 93.582 | 92.349 | 89.854 | 86.633 | 84.062 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -3.13793 | -3.14051 | -2.10665 | -0.88846 | -1.02805 |
| Popravljen normalizirani dobiček na enoto čistega dobička | -3.13793 | -3.14051 | -2.10665 | -0.88846 | -1.02805 |
| Skupaj izredne postavke | |||||
| Celotni stroški prihodkov | 20.28 | 12.871 | 8.869 | 1.147 | |
| Bruto dobiček | 120.454 | 222.438 | 167.45 | 255.43 | |
| Depreciation / Amortization | 0.587 | 4.639 | 10.369 | 10.307 | |
| Other Operating Expenses, Total | -3.373 | -1.271 | -1.201 | -1.385 | |
| Equity In Affiliates | 1.573 | 1.007 | -0.202 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 36.161 | 34.367 | 15.735 | 29.806 | 60.827 |
| Prihodki | 36.161 | 34.367 | 15.735 | 29.806 | 60.827 |
| Celotni stroški prihodkov | 3.491 | 4.925 | 4.308 | 6.809 | 4.238 |
| Bruto dobiček | 32.67 | 29.442 | 11.427 | 22.997 | 56.589 |
| Celotni odhodki iz poslovanja | 112.252 | 100.519 | 109.392 | 108.03 | 123.82 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 34.275 | 33.966 | 29.902 | 30.258 | 30.564 |
| Raziskave in razvoj | 74.486 | 61.628 | 75.182 | 70.963 | 89.018 |
| Other Operating Expenses, Total | |||||
| Prihodki iz poslovanja | -76.091 | -66.152 | -93.657 | -78.224 | -62.993 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -1.336 | -0.195 | 1.714 | 5.058 | -0.419 |
| Čisti dobiček pred obdavčitvijo | -77.427 | -66.347 | -91.943 | -73.166 | -63.412 |
| Čisti dobiček po davkih | -77.501 | -66.455 | -92.057 | -73.189 | -63.525 |
| Equity In Affiliates | 0.796 | 0.28 | 0.407 | 0.565 | 0.32 |
| Čisti dobiček pred dodatnimi postavkami | -76.705 | -66.175 | -91.65 | -72.624 | -63.205 |
| Čisti dobiček | -76.705 | -66.175 | -91.65 | -72.624 | -63.205 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -76.705 | -66.175 | -91.65 | -72.624 | -63.205 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -76.705 | -66.175 | -91.65 | -72.624 | -63.205 |
| Popravljen čisti dobiček | -76.705 | -66.175 | -91.65 | -72.624 | -63.205 |
| Popravljene ponderirane povprečne delnice | 94.691 | 94.035 | 93.767 | 93.475 | 93.043 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.81006 | -0.70373 | -0.97742 | -0.77694 | -0.67931 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.81006 | -0.70373 | -0.97742 | -0.77694 | -0.67931 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 492.826 | 474.059 | 755.11 | 702.49 | 690.015 |
| Denarna sredstva in kratkoročne naložbe | 422.008 | 405.19 | 686.537 | 533.757 | 621.402 |
| Cash | 135.819 | 111.422 | 88.046 | 40.715 | 38.783 |
| Denarna sredstva in ustrezniki | 19.881 | 59.801 | 590.347 | 85.551 | 50.475 |
| Kratkoročne naložbe | 266.308 | 233.967 | 8.144 | 407.491 | 532.144 |
| Celotne terjatve, neto | 16.299 | 25.401 | 41.883 | 153.665 | 63.684 |
| Accounts Receivable - Trade, Net | 28.387 | 36.331 | 46.01 | 158.51 | 16.474 |
| Prepaid Expenses | 9.73 | 7.383 | 8.353 | 6.464 | 4.929 |
| Total Assets | 610.087 | 773.821 | 826.84 | 857.397 | 880.598 |
| Property/Plant/Equipment, Total - Net | 100.933 | 120.15 | 65.296 | 84.276 | 127.198 |
| Property/Plant/Equipment, Total - Gross | 253.644 | 252.362 | 199.305 | 195.752 | 192.397 |
| Accumulated Depreciation, Total | -152.711 | -132.212 | -134.009 | -111.476 | -65.199 |
| Long Term Investments | 9.409 | 171.621 | 2.972 | 61.118 | 55.82 |
| Other Long Term Assets, Total | 6.919 | 7.991 | 3.462 | 9.513 | 7.565 |
| Total Current Liabilities | 273.562 | 225.497 | 163.187 | 102.745 | 89.033 |
| Accounts Payable | 30.758 | 26.097 | 24.789 | 6.088 | 9.139 |
| Accrued Expenses | 229.639 | 180.356 | 104.384 | 83.816 | 66.123 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 13.129 | 19.033 | 21.684 | 0.49 | 13.771 |
| Total Liabilities | 631.534 | 564.675 | 404.662 | 341.262 | 371.399 |
| Total Long Term Debt | 17.054 | 17.616 | 44.088 | 55.531 | 113.955 |
| Long Term Debt | 16.917 | 17.613 | 18.697 | 16.78 | 16.798 |
| Capital Lease Obligations | 0.137 | 0.003 | 25.391 | 38.751 | 97.157 |
| Minority Interest | 19.967 | 19.967 | 19.271 | 19.271 | 19.271 |
| Other Liabilities, Total | 320.951 | 292.403 | 169.441 | 163.715 | 149.14 |
| Total Equity | -21.447 | 209.146 | 422.178 | 516.135 | 509.199 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.942 | 0.929 | 0.914 | 0.877 | 0.854 |
| Additional Paid-In Capital | 1541.02 | 1476.41 | 1399.77 | 1300.72 | 1226.45 |
| Retained Earnings (Accumulated Deficit) | -1557.69 | -1264.03 | -974.011 | -784.72 | -715.827 |
| Other Equity, Total | -5.72 | -4.163 | -4.499 | -0.747 | -2.281 |
| Total Liabilities & Shareholders’ Equity | 610.087 | 773.821 | 826.84 | 857.397 | 880.598 |
| Total Common Shares Outstanding | 94.1661 | 92.881 | 91.441 | 87.657 | 85.432 |
| Total Inventory | 40.436 | 31.015 | 16.53 | 6.887 | |
| Other Current Assets, Total | 4.353 | 5.07 | 1.807 | 1.717 | |
| Current Port. of LT Debt/Capital Leases | 0.036 | 0.011 | 12.33 | 12.351 | |
| Deferred Income Tax | 9.192 | 8.675 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 430.549 | 492.826 | 474.224 | 520.643 | 524.415 |
| Denarna sredstva in kratkoročne naložbe | 355.949 | 422.008 | 408.52 | 438.133 | 428.075 |
| Cash | 145.81 | 135.819 | 104.509 | 128.152 | 165.436 |
| Denarna sredstva in ustrezniki | 42.74 | 19.881 | 51.451 | 39.606 | 20.46 |
| Kratkoročne naložbe | 167.399 | 266.308 | 252.56 | 270.375 | 242.179 |
| Celotne terjatve, neto | 17.654 | 16.299 | 15.328 | 33.573 | 43.883 |
| Accounts Receivable - Trade, Net | 29.217 | 28.387 | 29.665 | 60.352 | 82.638 |
| Total Inventory | 42.456 | 40.436 | 39.95 | 40.899 | 43.067 |
| Prepaid Expenses | 14.49 | 9.73 | 10.426 | 8.038 | 9.39 |
| Other Current Assets, Total | 4.353 | ||||
| Total Assets | 538.544 | 610.087 | 608.837 | 686.789 | 745.934 |
| Property/Plant/Equipment, Total - Net | 95.367 | 100.933 | 105.19 | 109.159 | 114.871 |
| Property/Plant/Equipment, Total - Gross | 253.644 | ||||
| Accumulated Depreciation, Total | -152.711 | ||||
| Long Term Investments | 5.884 | 9.409 | 22.411 | 50.414 | 97.643 |
| Other Long Term Assets, Total | 6.744 | 6.919 | 7.012 | 6.573 | 9.005 |
| Total Current Liabilities | 254.746 | 273.562 | 251.994 | 240.34 | 255.374 |
| Accounts Payable | 71.282 | 30.758 | 19.323 | 29.36 | 36.353 |
| Accrued Expenses | 166.969 | 229.639 | 224.577 | 202.681 | 211.518 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.036 | ||||
| Other Current Liabilities, Total | 16.495 | 13.129 | 8.094 | 8.299 | 7.503 |
| Total Liabilities | 587.396 | 631.534 | 582.531 | 583.009 | 587.886 |
| Total Long Term Debt | 17.276 | 17.054 | 15.422 | 16.439 | 17.374 |
| Long Term Debt | 17.276 | 16.917 | 15.422 | 16.439 | 17.374 |
| Capital Lease Obligations | 0.137 | ||||
| Deferred Income Tax | |||||
| Minority Interest | 19.967 | 19.967 | 19.967 | 19.967 | 19.967 |
| Other Liabilities, Total | 295.407 | 320.951 | 295.148 | 306.263 | 295.171 |
| Total Equity | -48.852 | -21.447 | 26.306 | 103.78 | 158.048 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
| Common Stock | 0.966 | 0.942 | 0.939 | 0.937 | 0.933 |
| Additional Paid-In Capital | 1589.15 | 1541.02 | 1524.23 | 1509.64 | 1490.86 |
| Retained Earnings (Accumulated Deficit) | -1634.39 | -1557.69 | -1491.51 | -1399.86 | -1327.24 |
| Other Equity, Total | -4.57 | -5.72 | -7.346 | -6.93 | -6.505 |
| Total Liabilities & Shareholders’ Equity | 538.544 | 610.087 | 608.837 | 686.789 | 745.934 |
| Total Common Shares Outstanding | 96.623 | 94.1661 | 93.936 | 93.733 | 93.289 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
| Denarna sredstva iz poslovanja | -145.933 | -82.232 | 81.602 | -78.705 | -76.144 |
| Denarna sredstva iz poslovanja | 10.604 | 14.809 | 22.047 | 21.454 | 6.562 |
| Nedenarne postavke | 66.687 | 132.899 | 74.216 | 62.47 | 52.112 |
| Denarna sredstva Plačane obresti | 0.104 | 0.094 | 0.135 | 0.174 | 0.218 |
| Spremembe v obratnem kapitalu | 70.43 | 60.083 | 174.63 | -85.659 | -48.398 |
| Denarna sredstva pri naložbenju | 89.116 | -426.972 | 452.487 | 120.018 | -522.123 |
| Kapitalski izdatki | -38.741 | -30.186 | -3.994 | -5.762 | -8.02 |
| Celotne druge postavke denarnih tokov pri naložbenju | 127.857 | -396.786 | 456.481 | 125.78 | -514.103 |
| Denarna sredstva pri financiranju | 46.776 | -0.563 | 13.343 | -4.3 | 13.875 |
| Postavke denarnega toka pri financiranju | -6.62 | -7.372 | -11.463 | -12.75 | -15.612 |
| Izdaja (odplačilo) delnic, neto | 53.934 | 12.701 | 37.829 | 20.778 | 29.847 |
| Izdaja (odplačilo) dolga, neto | -0.538 | -5.892 | -13.023 | -12.328 | -0.36 |
| Učinki deviznih tečajev | -5.482 | 2.597 | 4.695 | -0.005 | -0.008 |
| Neto sprememba denarnih sredstev | -15.523 | -507.17 | 552.127 | 37.008 | -584.4 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -76.705 | -293.654 | -227.479 | -135.829 | -63.205 |
| Cash From Operating Activities | -101.591 | -145.933 | -93.42 | -41.54 | -8.476 |
| Cash From Operating Activities | 2.965 | 10.604 | 7.914 | 5.235 | 2.584 |
| Non-Cash Items | 18.148 | 66.687 | 49.928 | 34.441 | 17.77 |
| Changes in Working Capital | -45.999 | 70.43 | 76.217 | 54.613 | 34.375 |
| Cash From Investing Activities | 103.482 | 89.116 | 88.023 | 43.24 | 25.935 |
| Capital Expenditures | -0.591 | -38.741 | -38.408 | -37.543 | -36.638 |
| Other Investing Cash Flow Items, Total | 104.073 | 127.857 | 126.431 | 80.783 | 62.573 |
| Cash From Financing Activities | 31.485 | 46.776 | -1.898 | -0.806 | -2.893 |
| Financing Cash Flow Items | 0 | -6.62 | -4.562 | -3.361 | -2.974 |
| Issuance (Retirement) of Stock, Net | 31.657 | 53.934 | 2.989 | 2.779 | 0.183 |
| Issuance (Retirement) of Debt, Net | -0.172 | -0.538 | -0.325 | -0.224 | -0.102 |
| Foreign Exchange Effects | -0.526 | -5.482 | -7.968 | -4.359 | 0.107 |
| Net Change in Cash | 32.85 | -15.523 | -15.263 | -3.465 | 14.673 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| PRIMECAP Management Company | Investment Advisor | 14.4767 | 14126697 | 231619 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.0286 | 8810326 | -613439 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.2737 | 6122003 | 89685 | 2023-03-31 | LOW |
| Astellas Pharma Inc | Corporation | 5.0915 | 4968367 | 0 | 2023-01-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.1772 | 4076167 | -188810 | 2023-03-31 | LOW |
| Point72 Asset Management, L.P. | Hedge Fund | 3.5113 | 3426427 | -1355218 | 2023-03-31 | HIGH |
| First Trust Advisors L.P. | Investment Advisor | 2.7884 | 2720975 | -254678 | 2023-03-31 | LOW |
| Baker Bros. Advisors LP | Hedge Fund | 2.7027 | 2637384 | 1262173 | 2023-03-31 | LOW |
| Armistice Capital LLC | Hedge Fund | 2.3693 | 2312000 | -1552000 | 2023-03-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7703 | 1727545 | 70450 | 2023-03-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.7676 | 1724909 | 512435 | 2023-03-31 | HIGH |
| Schroder Investment Management North America Inc. | Investment Advisor | 1.5138 | 1477161 | -246616 | 2023-03-31 | LOW |
| Artisan Partners Limited Partnership | Investment Advisor | 1.3847 | 1351230 | 1351230 | 2023-03-31 | LOW |
| Assenagon Asset Management S.A. | Investment Advisor | 1.3779 | 1344583 | 1344583 | 2023-03-31 | HIGH |
| Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.1877 | 1159027 | -348288 | 2023-03-31 | MED |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.1157 | 1088768 | 593915 | 2023-03-31 | LOW |
| Eventide Asset Management, LLC | Investment Advisor | 0.9838 | 960000 | 960000 | 2023-03-31 | MED |
| Nuveen LLC | Pension Fund | 0.9185 | 896293 | 328958 | 2023-03-31 | LOW |
| Adage Capital Management, L.P. | Hedge Fund | 0.8711 | 850000 | -1800000 | 2023-03-31 | MED |
| Eagle Asset Management, Inc. | Investment Advisor/Hedge Fund | 0.8488 | 828307 | -74825 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
FibroGen, Inc Company profile
O družbi FibroGen, Inc
FibroGen, Inc. je biofarmacevtsko podjetje. Podjetje se ukvarja z odkrivanjem, razvojem in trženjem nabora prvovrstnih zdravil. Družba uporablja svoje sposobnosti na področju biologije hipoksijo inducibilnega faktorja (HIF), encimologije 2-oksoglutarata in biologije rastnega faktorja vezivnega tkiva (CTGF) za razvoj zdravil za zdravljenje anemije, fibroznih bolezni in raka. Izdelek podjetja Roxadustat je peroralni zaviralec majhnih molekul aktivnosti HIF-prolil hidroksilaze (HIF-PH) za zdravljenje anemije zaradi kronične ledvične bolezni (CKD). Roxadustat razvija tudi za zdravljenje anemije, povezane z mielodisplastičnimi sindromi (MDS). Družba razvija tudi zdravilo Roxadustat za zdravljenje anemije, povzročene s kemoterapijo (CIA). Pamrevlumab, humano monoklonsko protitelo proti CTGF za zdravljenje idiopatske pljučne fibroze (IPF), lokalno napredovalega neresektabilnega raka trebušne slinavke (LAPC) in mišične distrofije Duchenne (DMD).
| Industry: | Biotechnology & Medical Research (NEC) |
409 Illinois Street
SAN FRANCISCO
CALIFORNIA 94158
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com